![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:4566Q Celsis International PLC 24 August 2005 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically. To: The FSA Date: 25 August 2005 AVS No: Name of applicant: CELSIS INTERNATIONAL PLC Name of scheme: UNAPPROVED SHARE SCHEME Period of return: From: 19 MARCH 1997 To: 24 AUGUST 2005 Balance under scheme from previous return: 60,000 The amount by which the block scheme has been increased, N/A if the scheme has been increased since the date of the last return: Number of securities issued/allotted under scheme during 60,000 period: Balance under scheme not yet issued/allotted at end of 0 period Number and class of securities originally listed and the 110,000 date of admission Total number of securities in issue at the end of the 112,415,218 period Name of contact: Christian Madrolle, Finance Director Address of contact: Suite 15, Lyndon House, Kings Court, Newmarket, Suffolk CB8 7SG Telephone number of contact: 01638 600 151 SIGNED BY CHRISTIAN MADROLLE Director/company secretary/suitably experienced employee/duly authorised officer, for and on behalf of CELSIS INTERNATIONAL PLC Name of applicant If you knowingly or recklessly give false or misleading information you may be liable to prosecution. This information is provided by RNS The company news service from the London Stock Exchange END BLRZGGZRVDGGKZM
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions